Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qinlian Jiangxia decoction
- Development stage
- Preclinical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Qinlian Jiangxia decoction (QLJXD) is a Traditional Chinese Medicine (TCM) herbal formula primarily investigated for its therapeutic potential in treating type 2 diabetes mellitus (T2DM) complicated by hyperlipidemia. The decoction is a multi-component mixture typically containing botanical ingredients such as *Scutellaria baicalensis* (Huangqin) and *Coptis chinensis* (Huanglian). Research utilizing network pharmacology, molecular docking, and molecular dynamics simulations suggests that QLJXD exerts its effects through a multi-target approach, primarily modulating the PI3K/Akt signaling pathway to improve glucose and lipid metabolism. It is also thought to regulate inflammatory cytokines and improve insulin sensitivity, thereby addressing the metabolic dysregulation characteristic of comorbid diabetes and dyslipidemia.
- Other names
- Qinlian Jiangxia formula
02
Targets
IL-6 (Interleukin 6)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)FABP4 (Fatty acid-binding protein 4)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)
Beyond the preview
Go deeper on Qinlian Jiangxia decoction.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qinlian Jiangxia decoction.